Apr 11 |
7 Top Stocks Under $7
|
Apr 8 |
Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
|
Mar 7 |
Elevation Oncology Inc (ELEV) Reports Financial Results for Q4 and Full Year 2023
|
Mar 6 |
Top 10 best performing biotech stocks of 2024 so far
|
Mar 6 |
Elevation Oncology GAAP EPS of -$0.19
|
Mar 6 |
Recap: Elevation Oncology Q4 Earnings
|
Mar 6 |
Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements
|
Mar 5 |
Trim the Fat: 3 Overbought Stocks Poised for a Pullback
|
Mar 5 |
Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024
|
Mar 4 |
Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. to Board of Directors
|